Диссертация (Гиперплазия простаты и мочекаменная болезнь в сочетании с новообразованиями органов мочеполовой системы), страница 46

2013. Т. 7. № 1112. — C. E716-21.21Chung S.D., Liu S.P., Lin H.C. Association between prostate cancer andurinary calculi: a population-based study // PLoS One. 2013. Т. 8. № 2. — C.e57743.22Chung S.D., Tsai M.C., Lin C.C., Lin H.C. A case-control study on theassociation between bladder cancer and prior bladder calculus // BMC Cancer. 2013.Т. 13. — C.

117.23Coe F.L., Evan A., Worcester E. Kidney stone disease // J Clin Invest. 2005.Т. 115. № 10. — C. 2598-608.24Cohen S.M., Johansson S.L., Arnold L.L., Lawson T.A. Urinary tractcalculi and thresholds in carcinogenesis // Food Chem Toxicol. 2002. Т. 40. № 6. —C. 793-9.25Curhan G.C. Epidemiology of stone disease // Urol Clin North Am. 2007. Т.34. № 3. — C. 287-93.26de la Rosette J.J., Alivizatos G., Madersbacher S., Perachino M., ThomasD., Desgrandchamps F., de Wildt M., European Association of U.

EAUGuidelines on benign prostatic hyperplasia (BPH) // Eur Urol. 2001. Т. 40. № 3. —C. 256-63; discussion 264.27Dellabella M., Branchi A., Gasparri L., Claudini R., Castellani D.Oncological safety and quality of life in men undergoing simultaneous transurethralresection of bladder tumor and prostate: results from a randomized controlled trial //World J Urol. 2018.

Т. 36. № 10. — C. 1629-1634.28Duncan W., Quilty P.M. The results of a series of 963 patients withtransitional cell carcinoma of the urinary bladder primarily treated by radicalmegavoltage X-ray therapy // Radiother Oncol. 1986. Т. 7. № 4. — C. 299-310.30729Eaton S.H., Cashy J., Pearl J.A., Stein D.M., Perry K., Nadler R.B.Admission rates and costs associated with emergency presentation of urolithiasis:analysis of the Nationwide Emergency Department Sample 2006-2009 // J Endourol.2013. Т. 27. № 12.

— C. 1535-8.30Etzioni R., Gulati R., Falcon S., Penson D.F. Impact of PSA screening onthe incidence of advanced stage prostate cancer in the United States: a surveillancemodeling approach // Med Decis Making. 2008. Т. 28. № 3. — C. 323-31.31Fazeli F., Gooran S., Taghvaei M.E., Fazeli K. Evaluating InternationalProstate Symptom Score (IPSS) in Accuracy for Predicting Post-Operative UrinaryRetention After Elective Cataract Surgery: A Prospective Study // Glob J Health Sci.2015. Т. 7. № 7 Spec No. — C. 93-6.32Fekak H., Rabii R., Moufid K., Joual A., Dahami Z., el Mrini M.

[Unusualclinical presentations of tumours of the renal pelvis. Report of two cases ] // ProgUrol. 2002. Т. 12. № 3. — C. 482-5.33Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // Int J Cancer.2010. Т. 127.

№ 12. — C. 2893-917.34Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M.,Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012 // Int J Cancer. 2015. Т.136. № 5. — C. E359-86.35Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., CoeberghJ.W., Comber H., Forman D., Bray F.

Cancer incidence and mortality patterns inEurope: estimates for 40 countries in 2012 // Eur J Cancer. 2013. Т. 49. № 6. — C.1374-403.36Ferraro P.M., Taylor E.N., Eisner B.H., Gambaro G., Rimm E.B.,Mukamal K.J., Curhan G.C. History of kidney stones and the risk of coronaryheart disease // JAMA. 2013. Т. 310. № 4. — C. 408-15.30837Garisto J.D., Dagenais J., Arora H., Bertolo R., Kaouk J.H. ConcurrentRobotic Pyelolithotomy and Partial Nephrectomy: Tips and Tricks // Urology. 2018.Т. 118. — C. 243.38Ghani K.R., Roghmann F., Sammon J.D., Trudeau V., Sukumar S.,Rahbar H., Kumar R., Karakiewicz P.I., Peabody J.O., Menon M., Sun M.,Trinh Q.D.

Emergency department visits in the United States for upper urinary tractstones: trends in hospitalization and charges // J Urol. 2014. Т. 191. № 1. — C. 906.39Gill I.S., Kamoi K., Aron M., Desai M.M. 800 Laparoscopic partialnephrectomies: a single surgeon series // J Urol. 2010. Т. 183. № 1. — C.

34-41.40Goldman G., Leviav A., Mazor A., Kashtan H., Aladgem D., GreensteinA., Wiznitzer T. Alpha-adrenergic blocker for posthernioplasty urinary retention.Prevention and treatment // Arch Surg. 1988. Т. 123. № 1. — C. 35-6.41Guess H.A., Arrighi H.M., Metter E.J., Fozard J.L. Cumulative prevalenceof prostatism matches the autopsy prevalence of benign prostatic hyperplasia //Prostate. 1990.

Т. 17. № 3. — C. 241-6.42Gulati R., Tsodikov A., Etzioni R., Hunter-Merrill R.A., Gore J.L.,Mariotto A.B., Cooperberg M.R. Expected population impacts of discontinuedprostate-specific antigen screening // Cancer. 2014. Т. 120. № 22. — C. 3519-26.43Hansen B.J., Rosenberg J., Andersen J.T. [Urinary retention in connectionwith postoperative pain treatment with epidural opioids] // Ugeskr Laeger. 1990. Т.152. № 22. — C. 1574-7.44Hashimoto K., Tsuji H., Hanai T., Katoh Y., Iguchi M.

[A case of renalcell carcinoma in a nonfunctioning kidney caused by staghorn calculus] // HinyokikaKiyo. 1998. Т. 44. № 2. — C. 93-5.45Hayat M.J., Howlader N., Reichman M.E., Edwards B.K. Cancerstatistics, trends, and multiple primary cancer analyses from the Surveillance,Epidemiology, and End Results (SEER) Program // Oncologist. 2007. Т. 12.

№ 1.— C. 20-37.30946Horn T., Seidl S., Gschwend J.E., Kubler H. Implantation metastasis ofprostate cancer in a suprapubic cystostomy tube needle tract // Prostate CancerProstatic Dis. 2010. Т. 13. № 3. — C. 292-4.47Howe G.R., Burch J.D., Miller A.B., Cook G.M., Esteve J., Morrison B.,Gordon P., Chambers L.W., Fodor G., Winsor G.M. Tobacco use, occupation,coffee, various nutrients, and bladder cancer // J Natl Cancer Inst.

1980. Т. 64. № 4.— C. 701-13.48Hsieh C.C., Thanos A., Mitropoulos D., Deliveliotis C., Mantzoros C.S.,Trichopoulos D. Risk factors for prostate cancer: a case-control study in Greece //Int J Cancer. 1999. Т. 80. № 5. — C. 699-703.49Hudak K.E., Frelich M.J., Rettenmaier C.R., Xiang Q., Wallace J.R.,Kastenmeier A.S., Gould J.C., Goldblatt M.I.

Surgery duration predicts urinaryretention after inguinal herniorrhaphy: a single institution review // Surg Endosc.2015. Т. 29. № 11. — C. 3246-50.50Ilic M., Vlajinac H., Marinkovic J. Case-control study of risk factors forprostate cancer // Br J Cancer. 1996. Т. 74. № 10. — C. 1682-6.51Jacobsen S.J., Jacobson D.J., Girman C.J., Roberts R.O., Rhodes T.,Guess H.A., Lieber M.M. Natural history of prostatism: risk factors for acuteurinary retention // J Urol. 1997. Т. 158. № 2. — C. 481-7.52Jain A., Mittal D., Jindal A., Solanki R., Khatri S., Parikh A., Yadav K.Incidentally detected squamous cell carcinoma of renal pelvis in patients withstaghorn calculi: case series with review of the literature // ISRN Oncol. 2011.

Т.2011. — C. 620574.53Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Globalcancer statistics // CA Cancer J Clin. 2011. Т. 61. № 2. — C. 69-90.54Jhamb M., Lin J., Ballow R., Kamat A.M., Grossman H.B., Wu X.Urinary tract diseases and bladder cancer risk: a case-control study // Cancer CausesControl. 2007. Т. 18. № 8. — C. 839-45.55Jiang X., Castelao J.E., Groshen S., Cortessis V.K., Shibata D., ContiD.V., Yuan J.M., Pike M.C., Gago-Dominguez M. Urinary tract infections and310reduced risk of bladder cancer in Los Angeles // Br J Cancer. 2009.

Т. 100. № 5. —C. 834-9.56Johnson C.M., Wilson D.M., O'Fallon W.M., Malek R.S., Kurland L.T.Renal stone epidemiology: a 25-year study in Rochester, Minnesota // Kidney Int.1979. Т. 16. № 5. — C. 624-31.57Johri N., Cooper B., Robertson W., Choong S., Rickards D., Unwin R. Anupdate and practical guide to renal stone management // Nephron Clin Pract. 2010.Т. 116. № 3. — C. c159-71.58Kang D., Chokkalingam A.P., Gridley G., Nyren O., Johansson J.E.,Adami H.O., Silverman D., Hsing A.W.

Benign prostatic hyperplasia andsubsequent risk of bladder cancer // Br J Cancer. 2007. Т. 96. № 9. — C. 1475-9.59Kaplan S.A., Olsson C.A., Te A.E. The American Urological Associationsymptom score in the evaluation of men with lower urinary tract symptoms: at 2years of followup, does it work? // J Urol. 1996. Т. 155. № 6. — C. 1971-4.60Katz R., Gofrit O.N., Golijanin D., Landau E.H., Shapiro A., Pode D.,Meretyk S. Urothelial cancer of the renal pelvis in percutaneous nephrolithotomypatients // Urol Int.

2005. Т. 75. № 1. — C. 17-20.61Kingo P.S., Ryhammer A.M., Fuglsig S. Clinical experience with the Swisslithoclast master in treatment of bladder calculi // J Endourol. 2014. Т. 28. № 10. —C. 1178-82.62Kjaer S.K., Knudsen J.B., Sorensen B.L., Moller Jensen O. TheCopenhagen case-control study of bladder cancer. V. Review of the role of urinarytract infection // Acta Oncol. 1989. Т. 28. № 5. — C. 631-6.63Kohjimoto Y., Sasaki Y., Iguchi M., Matsumura N., Inagaki T., Hara I.Association of metabolic syndrome traits and severity of kidney stones: results froma nationwide survey on urolithiasis in Japan // Am J Kidney Dis. 2013. Т. 61. № 6.— C. 923-9.64Kok E.T., Schouten B.W., Bohnen A.M., Groeneveld F.P., Thomas S.,Bosch J.L.

Risk factors for lower urinary tract symptoms suggestive of benign311prostatic hyperplasia in a community based population of healthy aging men: theKrimpen Study // J Urol. 2009. Т. 181. № 2. — C. 710-6.65Kouriefs C., Loizides S., Mufti G. Simultaneous transurethral resection ofbladder tumour and prostate: is it safe? // Urol Int. 2008. Т. 81. № 2.

— C. 125-8.66Kurauchi H., Machida T., Ohishi Y., Onodera S., Akasaka Y., Onishi T.,Ikemoto I., Yamasaki H. [Unexpected renal cell carcinomas found during theoperation in renal calculus: report of two cases] // Hinyokika Kiyo. 1988. Т. 34. №9. — C. 1617-20.67La Vecchia C., Franceschi S., Talamini R., Negri E., Boyle P., D'AvanzoB.